EVALUATION OF THE PROGRAM OF NEPHROPROTECTION IN PATIENTS WITH RENAL DISEASE OF A COLOMBIAN INSURANCE COMPANY.
Author(s)
Marino C1, Romero M2, Cruz AM3, Barrera J4, Celis S2, Gallo D2
1Coomeva, Bogotá, Colombia, 2Fundación Salutia, Bogotá, Colombia, 3Coomeva EPS, Cali, Colombia, 4Fundación Salutia, Bogotá D.C., Colombia
OBJECTIVES: To evaluate the impact of the nephroprotection program through clinical data in patients with arterial hypertension and Diabetes Mellitus precursor disease of an insurer in Colombia METHODS: From the extraction of data from the database of patients with kidney disease from a Colombian insurer, two types of analysis were carried out: Descriptive and Inferential. The descriptive analysis contains a characterization of the clinical and sociodemographic variables of the population. The inferential analysis, carried out through the statistical package Stata 14, had as a tool a methodology of comparison of means in order to verify the effectiveness of the program and the impact on the affiliated population. RESULTS: A total of 115,210 users with an average age of 68.34 years were analyzed, predominantly in females with a decrease in BMI in 61% of cases. Of the patients in the nephroprotection program, 89.6% did not present changes in the stage and only 3.3% presented regression in them. The statistical analysis showed a progression in the stages in 7.1% with a mean difference of 0.01%, which was statistically significant (p = 0.000) 95% CI (0.025- 0.014). In relation to precursor disease, in 60% of the patients it was Arterial Hypertension which coincides with the national statistics. In 59.6% of diabetics had HbA1c levels below 7%. In the years 2016 and 2017, 5.8% of the patients who entered the nephroprotection program had dialysis therapy, the majority (98%) in stage 5. CONCLUSIONS: It is evident that the nephroprotection program has coverage in 61% of the population with kidney disease, with good levels of control of it; with utility in the control but not in regression of the stages and with better control in the advanced stages that delay the implementation of dialysis.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PUK23
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Treatment Patterns and Guidelines
Disease
Urinary/Kidney Disorders